Skip to main content
All Articles 🧪 Evidence 🔍 Search About 🌏 中文版 (Chinese)
← Back to all articles
Saw Palmetto vs Finasteride (2026): Is the Natural DHT Blocker as Good as the Drug?

Saw Palmetto vs Finasteride (2026): Is the Natural DHT Blocker as Good as the Drug?

Saw palmetto and finasteride both block the enzyme that makes DHT — but one is a weak, reversible botanical and the other a potent, FDA-approved drug. Here is the honest head-to-head on effectiveness, side effects, evidence, and who each one is actually for.

Post-Finasteride Syndrome (2026): What It Is, What the Evidence Shows, and What to Do

Post-Finasteride Syndrome (2026): What It Is, What the Evidence Shows, and What to Do

Post-finasteride syndrome describes persistent sexual, neurological and mood symptoms after stopping finasteride. It is rare, contested in its mechanisms, real for the people who experience it, and surrounded by more heat than light. Here is the evidence-grounded version.

Finasteride for Hair Loss: The Complete Guide (2026)

Finasteride for Hair Loss: The Complete Guide (2026)

Oral finasteride is the most-studied prescription hair-loss treatment, with three decades of randomised trial data, a well-characterised effect size, and a side-effect profile that is real but smaller and rarer than internet anecdote suggests. Here is the decision-first guide — efficacy, dosing, side effects, who should and shouldn't take it, and how to start.

Finasteride vs Dutasteride for Hair Loss (2026): Which One, When, and Why

Finasteride vs Dutasteride for Hair Loss (2026): Which One, When, and Why

Dutasteride suppresses 90% of scalp DHT vs finasteride's 70% — but it's off-label, more expensive, and has a 5-week half-life. The actual head-to-head comparison and a decision tree.

Finasteride Side Effects: What the Real RCT Data Shows (2026)

Finasteride Side Effects: What the Real RCT Data Shows (2026)

Forum threads paint finasteride as terrifying. The published trial data tells a more measured story. Here are the actual numbers — sexual, mood, prostate-related — across 14,000+ patients.